Overview
Xaira Therapeutics was jointly incubated by ARCH Venture Partners, one of the largest biotechnology investors, and Foresite Labs. In addition…
Funding
Amounts as reported; USD estimates shown only when they matchListed 2 funding records. Latest funding: $800M (Series A), Aug 15, 2025.
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 2 valuation records. Latest valuation: $3.55B (post-money) (Series A), Aug 15, 2025.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Aug 15, 2025 | $3.55B (post-money) · Series A | ARCH Venture Partners, F-Prime, Foresite Capital, Lightspeed Venture Partners, Lux Capital, NEA, Sequoia Capital | 1 source Source ↗ |
Evidence Xaira Therapeutics raises $800M Series A at $3.55B valuationOn 2025-8-15, according to PitchBook, Xaira Therapeutics completed a USD 800 million Series A financing at a USD 3.55 billion valuation Translated source brief, not a quotation. Check the original before citing. Sources · 1
ARCH Venture Partners, F-Prime, Foresite Capital, Lightspeed Venture Partners, Lux Capital, NEA, Sequoia Capital | |||
| Apr 23, 2024 | — · Series A | ARCH Venture Partners, F-Prime, Foresite Capital, Lightspeed Venture Partners, Lux Capital, Menlo Ventures, NEA, Parker Institute for Cancer Immunotherapy, R-Squared Ventures, Sequoia Capital, SV Angel, Two Sigma Ventures, 拜耳 | No source link |
Evidence No source brief is attached to this record. Sources · 0
ARCH Venture Partners, F-Prime, Foresite Capital, Lightspeed Venture Partners, Lux Capital, Menlo Ventures, NEA, Parker Institute for Cancer Immunotherapy, R-Squared Ventures, Sequoia Capital, SV Angel, Two Sigma Ventures, 拜耳 | |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Explore
More Industry apps companies
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
Xaira Therapeutics是一家美国的生物科技公司 Xaira Therapeutics由生物技术领域最大的投资机构之一ARCH Venture Partners和Foresite Labs联合孵化。此外